2011 Focus On Lung Cancer - a full day symposium designed to address the personal and medical issues facing lung cancer survivors, their loved ones, and caregivers. Listen to a panel of integrative medicine and wellness experts discuss cancer rehabilitation, cardiology, reiki and mindfulness for lung cancer patients. Also hear survivor stories from lung cancer patients and their loved ones. See more here: 2011 Focus On Lung Cancer - Integrative Medicine, Wellness Cases … Continue reading →

2011 Focus On Lung Cancer - a full day symposium designed to address the personal and medical issues facing lung cancer survivors, their loved ones, and caregivers. This audio file features the Small Cell Lung Cancer workshop. The rest is here: 2011 Focus On Lung Cancer -- Small Cell Lung Cancer (Part 5 of 7) - Video … Continue reading →

Volker Diehl, MD, Professor of Medicine, Emeritus, University of Cologne, Germany, discusses the recently approved drug brentuximab vedotin (SGN-35), an antibody-drug conjugate that has been approved to treat anaplastic large cell lymphoma (ALCL) and Hodgkin lymphoma. It is marketed as Adcetris by Seattle Genetics, Inc. Brentuximab vedotin builds on the CD30 tumor marker discovered 30 years ago in cell line L428 View post: Dr. Diehl Discusses Brentuximab Vedotin - Video … Continue reading →